Taysha Gene Therapies Reports First Quarter 2022 Financial Results and Provides Corporate Update
Go back to Taysha Gene Therapies Reports First Quarter 2022 Financial Results and Provides Corporate Update| (NASDAQ: TSHA) | Delayed: 5.16 +0.09 (1.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.07 | 52 Week High | $ | |||
| Open | $5.25 | 52 Week Low | $ | |||
| Day High | $5.46 | P/E | N/A | |||
| Day Low | $5.05 | EPS | $ | |||
| Volume | 4,082,271 | |||||
